PainReform Receives Nasdaq Non-Compliance Letter
Ticker: PRFX · Form: 6-K · Filed: May 31, 2024 · CIK: 1801834
| Field | Detail |
|---|---|
| Company | Painreform Ltd. (PRFX) |
| Form Type | 6-K |
| Filed Date | May 31, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | bearish |
Sentiment: bearish
Topics: listing-compliance, nasdaq, regulatory-action
TL;DR
Nasdaq sent PainReform a non-compliance letter for low stock price, they have a plan to fix it or risk delisting.
AI Summary
On May 31, 2024, PainReform Ltd. announced it received a letter from Nasdaq Listing Qualifications. The company is required to submit a plan to regain compliance with Nasdaq's minimum bid price requirement.
Why It Matters
This letter indicates PainReform may face delisting from the Nasdaq Stock Market if it cannot regain compliance with the minimum bid price rule.
Risk Assessment
Risk Level: medium — The company is at risk of being delisted from Nasdaq if it cannot meet the minimum bid price requirement.
Key Players & Entities
- PainReform Ltd. (company) — The company filing the report and receiving the Nasdaq letter.
- Nasdaq Listing Qualifications (company) — The department that issued the non-compliance letter.
- May 31, 2024 (date) — The date the press release announcing the Nasdaq letter was issued.
FAQ
What is the primary reason for PainReform Ltd. receiving a letter from Nasdaq Listing Qualifications?
PainReform Ltd. received the letter because it is not in compliance with Nasdaq's minimum bid price requirement.
What is the deadline for PainReform Ltd. to submit a plan to regain compliance?
The filing does not specify a deadline for submitting the plan, but indicates the company must submit one to regain compliance.
What are the potential consequences if PainReform Ltd. fails to regain compliance?
If PainReform Ltd. fails to regain compliance, its securities may be delisted from the Nasdaq Stock Market.
What is the filing type and date?
This is a Form 6-K filed on May 31, 2024.
What is PainReform Ltd.'s principal executive office address?
PainReform Ltd.'s principal executive offices are located at 65 Yigal Alon St., Tel Aviv 6744316 Israel.
Filing Stats: 231 words · 1 min read · ~1 pages · Grade level 8.8 · Accepted 2024-05-31 16:24:01
Filing Documents
- zk2431539.htm (6-K) — 10KB
- exhibit_99-1.htm (EX-99.1) — 11KB
- 0001178913-24-001915.txt ( ) — 22KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: May 31, 2024 PAINREFORM LTD. By: /s/ Ilan Hadar Ilan Hadar Chief Executive Officer